Shanghai Haohai Biological Technology Co., Ltd. (688366.SS)
CNY 62.26
(-0.91%)
CNY 62.26
(-0.91%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 705.57 Million | 231.29 Million | 342.28 Million | 262.07 Million | 348.91 Million | 391.28 Million |
| Net Income | 416.12 Million | 235.72 Million | 382.64 Million | 257.02 Million | 434.34 Million | 525.18 Million |
| Depreciation & Amortization | 197.85 Million | 204.21 Million | 162.83 Million | 132.87 Million | 115.42 Million | 83.61 Million |
| Deferred income taxes | -1.94 Million | - | - | -15.42 Million | -23.3 Million | -6.82 Million |
| Stock-based compensation | 14.3 Million | 30.22 Million | - | - | - | - |
| Change in working capital | 70.99 Million | -183.49 Million | 23.92 Million | 66.91 Million | -40.48 Million | -41.07 Million |
| Other non-cash items | 8.25 Million | -55.38 Million | -227.12 Million | -194.73 Million | -160.37 Million | -176.44 Million |
| Investing Cash Flow | -700.79 Million | -681.81 Million | -148.09 Million | 316.92 Million | -1.13 Billion | -794.63 Million |
| Investments in PPE | -267.23 Million | -317.14 Million | -272.09 Million | -195.86 Million | -399.3 Million | -151.87 Million |
| Acquisitions | -243.88 Million | 14.65 Million | -83.27 Million | -88.4 Million | -57.09 Million | -433.8 Million |
| Investment purchases | -204.24 Million | -528.78 Million | -696.61 Million | -273.86 Million | -1.3 Billion | -281.56 Million |
| Sales/Maturities of investments | 14.56 Million | 9.06 Million | 749.27 Million | 649.28 Million | 166.33 Million | 665 Thousand |
| Other Investing Activities | -111.04 Million | 140.4 Million | 154.61 Million | 225.76 Million | 456.78 Million | 71.93 Million |
| Financing Cash Flow | -6.9 Million | -288.35 Million | -231.25 Million | -190.06 Million | 1.39 Billion | -85.33 Million |
| Debt repayment | -297.5 Million | -47.91 Million | -95.53 Million | -49.89 Million | -79.51 Million | -42.27 Million |
| Dividends payments | -68.51 Million | -121.89 Million | -87.91 Million | -124.04 Million | -80.02 Million | -80.02 Million |
| Common Stock Repurchased | -269.97 Million | -147.67 Million | -44.9 Million | -50.95 Million | - | - |
| Common Stock Issuance | 73.68 Million | - | -3.95 Million | 84.82 Million | 1.53 Billion | - |
| Other Financing Activities | -15.05 Million | 29.12 Million | 1.05 Million | -50 Million | 13.02 Million | 36.97 Million |
| Accounts receivables | 16.05 Million | -44.87 Million | -34.67 Million | 17.65 Million | -16.66 Million | -74.63 Million |
| Accounts payables | 43.48 Million | 35.44 Million | 32.34 Million | 52.91 Million | 10.31 Million | 36.14 Million |
| Inventory | -48.41 Million | -138.85 Million | -28.62 Million | -18.68 Million | -27.86 Million | -23.18 Million |
| Other working capital | 59.86 Million | -35.19 Million | 54.88 Million | 15.02 Million | -6.27 Million | -17.88 Million |
| Cash at beginning of period | 2.54 Billion | 1.28 Billion | 1.32 Billion | 944.5 Million | 335.62 Million | 821.88 Million |
| Cash at end of period | 2.73 Billion | 559.19 Million | 1.28 Billion | 1.32 Billion | 944.5 Million | 335.62 Million |
| Capital Expenditure | -267.23 Million | -317.14 Million | -272.09 Million | -195.86 Million | -399.3 Million | -151.87 Million |
| Effect of forex changes on cash | 10.04 Million | 14.17 Million | -6.93 Million | -5.55 Million | 3.16 Million | 2.42 Million |
| Net cash flow / Change in cash | 198.28 Million | -724.69 Million | -43.99 Million | 383.38 Million | 608.88 Million | -486.26 Million |
| Free Cash Flow | 438.34 Million | -85.85 Million | 70.18 Million | 66.21 Million | -50.38 Million | 239.41 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 105.6 Million | 137.74 Million | 97.54 Million | 89.31 Million | 416.12 Million | 121.56 Million |
| Depreciation & Amortization | - | 49.28 Million | 49.28 Million | 48.16 Million | 197.85 Million | 48.16 Million |
| Deferred income taxes | - | - | - | - | -1.94 Million | - |
| Stock-based compensation | - | 2.37 Million | - | 14.67 Million | 14.3 Million | -11.82 Million |
| Change in working capital | - | 33.01 Million | - | 29.7 Million | 70.99 Million | - |
| Other non-cash items | 3.68 Million | 192.83 Million | 12.98 Million | 109.62 Million | 8.25 Million | -62.13 Million |
| Investing Cash Flow | -10.73 Million | -27.77 Million | 130.14 Million | -275.77 Million | -700.79 Million | -142.18 Million |
| Investments in PPE | -57.42 Million | -68.89 Million | -153.7 Million | -68.95 Million | -267.23 Million | -91.74 Million |
| Acquisitions | 78.85 Thousand | -15.11 Million | 5.57 Million | -291.61 Million | -243.88 Million | -499 Thousand |
| Investment purchases | -112.49 Million | -103.86 Million | -827.25 Million | -33.78 Million | -204.24 Million | -1.03 Billion |
| Sales/Maturities of investments | 159.1 Million | 160.1 Million | 1.1 Billion | 118.59 Million | 14.56 Million | 1.02 Billion |
| Other Investing Activities | - | -16.71 Million | 312.99 Million | -1.00 | -111.04 Million | -38.29 Million |
| Financing Cash Flow | -101.98 Million | -176.78 Million | 36.72 Million | 192.88 Million | -6.9 Million | -205.51 Million |
| Debt repayment | -27.15 Million | -9.28 Million | -17.84 Million | -85.4 Million | -297.5 Million | -846.88 Thousand |
| Dividends payments | - | -139.4 Million | -2.96 Million | -68.51 Million | -68.51 Million | -70.53 Million |
| Common Stock Repurchased | 61.11 Million | -61.11 Million | - | -269.97 Million | -269.97 Million | 21.52 Million |
| Common Stock Issuance | - | - | - | -24.54 Million | 73.68 Million | - |
| Other Financing Activities | -190.24 Million | -113.37 Million | 18.87 Million | 470.52 Million | -15.05 Million | -226.18 Million |
| Accounts receivables | - | -64.17 Million | - | 10.13 Million | 16.05 Million | - |
| Accounts payables | - | - | - | - | 43.48 Million | - |
| Inventory | - | 9.72 Million | - | -48.41 Million | -48.41 Million | - |
| Other working capital | - | 87.45 Million | - | 67.99 Million | 59.86 Million | - |
| Cash at beginning of period | 2.66 Billion | 2.67 Billion | 2.74 Billion | 2.65 Billion | 2.54 Billion | 651.66 Million |
| Cash at end of period | 2.62 Billion | 2.66 Billion | 2.67 Billion | 2.74 Billion | 2.73 Billion | 406.36 Million |
| Capital Expenditure | -57.42 Million | -68.89 Million | -153.7 Million | -68.95 Million | -267.23 Million | -91.74 Million |
| Effect of forex changes on cash | - | 1.28 Million | -524.41 Thousand | -1.26 Million | 10.04 Million | -5.2 Million |
| Net cash flow / Change in cash | -41.74 Million | -10.44 Million | -63.23 Million | 86.69 Million | 198.28 Million | -245.3 Million |
| Free Cash Flow | 51.86 Million | 212.39 Million | -43.16 Million | 178.14 Million | 438.34 Million | 15.84 Million |
BETS-B
249420
GMTD
KAZT
CNBW
600219